Qing-Re-Chu-shi decoction ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice through anti-inflammation and immunoregulatory mechanisms

医学 特应性皮炎 免疫球蛋白E 免疫学 脾脏 汤剂 嗜酸性粒细胞 促炎细胞因子 炎症 药理学 抗体 内科学 哮喘
作者
Y. Meng,Yu Liu,Jianning Guo,Xiao-Yao Guo,Xuyang Han,Lu Zhang,Tingting Di,Jingxia Zhao,Yan Wang,Ping Li
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:323: 117702-117702 被引量:4
标识
DOI:10.1016/j.jep.2024.117702
摘要

Qing-Re-Chu-Shi Decoction (QRCSD), a traditional Chinese herbal formula, has been employed as a complementary and alternative therapy for inflammatory skin diseases. However, its active constituents and the mechanistic basis of its action on atopic dermatitis remain in adequately understood. Atopic dermatitis (AD) is an allergic dermatitis marked by eczematous lesions and pruritus. The study aimed to elucidate the underlying effects of QRCSD on AD and to identify the components responsible for its therapeutic efficacy in a mouse model. Network pharmacology and UPLC-mass analysis were used to anticipate the pharmacological mechanisms and to identify active components of QRCSD, respectively. A DNCB-induced AD-like model was established in NC/Nga mice. QRCSD or prednisolone (as a positive control) was administered via gavage every other day from day14 to day 21. Dermatitis severity score, scratching behavior, skin barrier function, spleen index, Th1/Th2 lymphocyte ratio, and serum IgE levels were evaluated. Protein arrays, including 40 inflammatory cytokines, were performed on skin lesions, followed by confirmation experiments of Western blotting in dorsal skin lesions. The construction of a QRCSD-AD-Network and topological analysis firstly proposed potential targets of QRCSD acting on AD. Animal experiments demonstrated that oral administration of QRCSD ameliorated AD-like lesions, reduced epidermal thickness and mast cell count, decreased serum IgE levels, augmented tight junction protein (Claudin 1, Occludin) levels, and regulated the Th1/Th2 balance in the spleen, as well as spleen index. Elevated levels of interleukin (IL)-4, IL-5, IL-6, IL-17, and Eotaxin were revealed in AD-like skin lesions by protein arrays. Western blotting confirmed that the phosphorylation levels of ERK, P38, JNK, STAT3 and P65 were downregulated, and IL-6 expression was also reduced following QRCSD treatment. The study enhances the understanding of the anti-inflammatory and immunomodulatory effects of QRCSD, showcasing its significant protective role against atopic dermatitis. Treatment with QRCSD may be considered as a viable candidate for complementary and alternative therapy in managing atopic dermatitis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
欣慰的星月完成签到,获得积分10
1秒前
FashionBoy应助潇湘雪月采纳,获得10
4秒前
传奇3应助leanne采纳,获得10
4秒前
大模型应助Heartlark采纳,获得10
6秒前
8秒前
moxi摩西完成签到,获得积分10
8秒前
卷卷完成签到,获得积分10
10秒前
时笙发布了新的文献求助10
11秒前
11秒前
pterion完成签到,获得积分10
11秒前
11秒前
13秒前
哒哒完成签到,获得积分10
15秒前
15秒前
循环发布了新的文献求助10
15秒前
幽默毛衣发布了新的文献求助10
18秒前
20秒前
循环完成签到,获得积分10
20秒前
leanne发布了新的文献求助10
20秒前
21秒前
量子星尘发布了新的文献求助10
21秒前
22秒前
22秒前
开灯人和关灯人完成签到,获得积分20
23秒前
Stardust发布了新的文献求助10
24秒前
25秒前
FashionBoy应助爱笑晓曼采纳,获得10
26秒前
张雯思发布了新的文献求助10
27秒前
Priority完成签到,获得积分10
28秒前
光热效应发布了新的文献求助30
28秒前
风之星给风之星的求助进行了留言
28秒前
28秒前
ASH发布了新的文献求助10
28秒前
OxO完成签到,获得积分10
28秒前
29秒前
搜集达人应助快乐一江采纳,获得10
29秒前
30秒前
leanne完成签到,获得积分20
31秒前
幽默毛衣完成签到,获得积分10
32秒前
晨曦完成签到,获得积分10
32秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989390
求助须知:如何正确求助?哪些是违规求助? 3531487
关于积分的说明 11254109
捐赠科研通 3270153
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809174